BRIEF published on 01/23/2025 at 06:50, 10 months 13 days ago Galenica records solid growth in 2024 EBIT Galenica Growth 2024 Logistics & IT Swiss Pharmacy
PRESS RELEASE published on 01/23/2025 at 06:45, 10 months 13 days ago Galenica reports strong sales growth once again Galenica reports strong sales growth once again in 2024, outperforming pharmaceutical market. Guidance for 2024 annual results confirmed, projecting EBIT growth between 8%-11% Sales Growth EBIT Growth Galenica Pharmaceutical Market 2024 Results
BRIEF published on 10/24/2024 at 06:50, 1 year 1 month ago Galenica Reports Robust Sales Growth in Third Quarter Sales Growth Pharmaceutical Market Galenica AG Generics And Biosimilars Logistics & IT
PRESS RELEASE published on 10/24/2024 at 06:45, 1 year 1 month ago Galenica increases sales growth in the third quarter Galenica reports 4.1% sales growth in the third quarter of 2024, outperforming the pharmaceutical market. Confirms sales growth outlook for 2024 2024 Outlook Sales Growth Galenica Pharmaceutical Market Third Quarter
BRIEF published on 08/06/2024 at 07:05, 1 year 3 months ago Expansion of management and handover to the position of CFO at Galenica CFO Reorganization Strategy Galenica Pharmacies
PRESS RELEASE published on 08/06/2024 at 07:00, 1 year 3 months ago Expansion of the Executive Committee and handover of the position of CFO Galenica restructures its executive team to enhance customer focus. CFO Felix Burkhard to step down by end of 2024, Julian Fiessinger to take over. Strategic aims include growth and improved customer satisfaction CFO Restructuring Growth Galenica Customer Focus
BRIEF published on 08/06/2024 at 06:50, 1 year 3 months ago Galenica Reports Solid Growth Amid Challenging Market Conditions Sales Growth Galenica IT Infrastructure Pharmacy Market Generic Medicines
PRESS RELEASE published on 08/06/2024 at 06:45, 1 year 3 months ago Galenica achieves solid growth in a challenging market environment Galenica achieves solid growth in the first half of 2024 with 2.6% sales increase, confirming 2024 guidance. 10.7% EBIT growth seen, with various successes in healthcare services and market expansion Sales Growth Market Expansion Galenica EBIT Increase Healthcare Services
BRIEF published on 07/22/2024 at 18:16, 1 year 4 months ago Galenica Increases Stake in Redcare Pharmacy to 10% Investment Shareholding Redcare Pharmacy Galenica Pharmacy
PRESS RELEASE published on 07/22/2024 at 18:11, 1 year 4 months ago Galenica increases shareholding in Redcare Pharmacy to 10% Galenica increases stake in Redcare Pharmacy to 10% as part of strategic partnership, aiming for long-term investment benefits Strategic Partnership Investment Redcare Pharmacy Online Pharmacy Galenica
Published on 12/05/2025 at 02:35, 4 hours 36 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 11 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 6 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 11 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 11 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 40 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 20 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 45 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 56 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 11 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 26 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 27 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
